Lisdexamfetamine Dimesylate Capsule
Product Images NDC 0406-5113
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Lisdexamfetamine Dimesylate (NDC 0406-5113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Specgx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (10 mg Capsules)
Principal Display Panel (20 mg Capsules)
Principal Display Panel (30 mg Capsules)
Principal Display Panel (40 mg Capsules)
Principal Display Panel (50 mg Capsules)
Principal Display Panel (60 mg Capsules)
Principal Display Panel (70 mg Capsules)
Figure 1 (Lisdexamfetamine Dimesylate 2)
Special Population: This description provides information regarding a special population. It includes details about gender (male/female), age (6578 years and >=75 years), renal impairment (mild, moderate, severe, end-stage renal disease), and various measurements such as PK, Coms, AUC, Coue, G, Come, and Fold Change. Additionally, it mentions 90% confidence intervals and a change relative to reference. However, the text seems to be incomplete or garbled, making it difficult to ascertain the full meaning or purpose of these details.*
Figure 2 (Lisdexamfetamine Dimesylate 3)
Figure 3 (Lisdexamfetamine Dimesylate 4)
Figure 4 (Lisdexamfetamine Dimesylate 5)
Figure 5-1 (Lisdexamfetamine Dimesylate 6)
Figure 6 (Lisdexamfetamine Dimesylate 7)
Figure 7 (Lisdexamfetamine Dimesylate 8)
Figure 8 (Lisdexamfetamine Dimesylate 9)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.